Biogroup CFO Sees Huge Demand in Covid-19 Testing

The video discusses the uncertainty surrounding the AstraZeneca vaccine timeline, highlighting the challenges in deployment, especially for older populations. It explores the impact of COVID-19 on laboratory productivity, emphasizing the increased demand for testing. The need for significant investment in new PCR testing equipment is discussed, along with the strategic decisions made by the industry to consolidate and expand, particularly in France and Belgium.

What was the significance of the acquisition made in Belgium for the company?

In what ways did the speaker suggest that the industry could benefit from diversifying geographically?